Advertisement

Banner BIO Deutschland European Business Development Conference 600x60px
Organisation › Details

Antisense Pharma GmbH

Antisense Pharma is a pioneer in the development of antisense drugs. Discovered with the help of modern platform technology, the drugs effectively prevent disease-associated proteins to originate. This allows to tackle fatal diseases like cancer at their roots - fighting them causally rather than symptomatically.

The product pipeline comprises agents against malignant brain tumors, colorectal carcinoma, pancreatic carcinoma and malignant melanoma as well as other forms of tumors in various stages of clinical and pre-clinical development. Antisense Pharma has been awarded the Bavarian Innovation Prize as well as the German Founders Award. In addition to MIG-Fonds and along with private investors other venture capital companies like Global Chance Fund, Global Asset Fund, S-Refit, TechnologiebeteiligungsGesellschaft mbH and the Techonologie Beteiligunsgfonds GmbH & Co. KG. are actively involved in Antisense Pharma. *

 

Period Start 1998-01-01 established
Period End 2013-09-30 renamed
  Group Isarna Therapeutics GmbH
  Today Isarna Therapeutics GmbH
  Successor Isarna Therapeutics GmbH
Products Industry antisense drug
  Industry 2 cancer drug
Persons Person Calais, Philippe (Antisense Pharma 201205– Managing Director CEO before Roche + ICI et al)
  Person 2 Heinrichs, Hubert (Antisense Pharma 201012 Managing Director)
     
Region Region Regensburg
  Country Germany
  Street 9 Josef-Engert-Str.
  City 93053 Regensburg
  Tel +49-941-9201-300
  Fax +49-941-9201-329
    Address record changed: 2010-12-22
     
Basic data Employees C: 51 to 100 (2008-10-01)
     
    * Document for »About Section«: Antisense Pharma GmbH. (11/08/07). "Press Release: €27 Million/$38 Million Venture Capital for Specialist in Cancer Therapeutics". Regensburg.
     
   
Record changed: 2014-03-20

Advertisement

Banner Fairtec GmbH We Optimise the ROI of Your Event 600x60px

More documents for Isarna Therapeutics GmbH


To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Highl Successful LC/MS Niche Player Is Looking for a Junior Partner 600x60px




» top

Advertisements

Banner BIO Deutschland European Business Development Conference 120x240px Banner LSBC Central European Life Science Investment Conference 2014 120x180px Banner EBD Group BIO Europe 2013 BEU Frankfurt November 120x180px Erfolgreicher Nischenanbieter im LC/MS-Markt sucht Junior-Partner 120x240px Banner Vego Ltd Ecochem Conference 2014 Basel 120x120px The Events Group Pharm Connect Congress 2015 Budapest February 120x180px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Banner [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px